                         SEQUENCE LISTING

<110>  KEYOMARSI, KHANDAN
       DELK, NIKKI
       HUNT, KELLY K.
       WINGATE, HANNAH
       MITTENDORF, ELIZABETH A.
 
<120>  LOW MOLECULAR WEIGHT CYCLIN E (LMW-E) AS A BIOMARKER FOR 
       PERSONALIZATION OF CANCER THERAPIES

<130>  CLFR:335WO

<140>  UNKNOWN
<141>  2010-03-10

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  410
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Pro Arg Glu Arg Arg Glu Arg Asp Ala Lys Glu Arg Asp Thr Met 
1               5                   10                  15      


Lys Glu Asp Gly Gly Ala Glu Phe Ser Ala Arg Ser Arg Lys Arg Lys 
            20                  25                  30          


Ala Asn Val Thr Val Phe Leu Gln Asp Pro Asp Glu Glu Met Ala Lys 
        35                  40                  45              


Ile Asp Arg Thr Ala Arg Asp Gln Cys Gly Ser Gln Pro Trp Asp Asn 
    50                  55                  60                  


Asn Ala Val Cys Ala Asp Pro Cys Ser Leu Ile Pro Thr Pro Asp Lys 
65                  70                  75                  80  


Glu Asp Asp Asp Arg Val Tyr Pro Asn Ser Thr Cys Lys Pro Arg Ile 
                85                  90                  95      


Ile Ala Pro Ser Arg Gly Ser Pro Leu Pro Val Leu Ser Trp Ala Asn 
            100                 105                 110         


Arg Glu Glu Val Trp Lys Ile Met Leu Asn Lys Glu Lys Thr Tyr Leu 
        115                 120                 125             


Arg Asp Gln His Phe Leu Glu Gln His Pro Leu Leu Gln Pro Lys Met 
    130                 135                 140                 


Arg Ala Ile Leu Leu Asp Trp Leu Met Glu Val Cys Glu Val Tyr Lys 
145                 150                 155                 160 


Leu His Arg Glu Thr Phe Tyr Leu Ala Gln Asp Phe Phe Asp Arg Tyr 
                165                 170                 175     


Met Ala Thr Gln Glu Asn Val Val Lys Thr Leu Leu Gln Leu Ile Gly 
            180                 185                 190         


Ile Ser Ser Leu Phe Ile Ala Ala Lys Leu Glu Glu Ile Tyr Pro Pro 
        195                 200                 205             


Lys Leu His Gln Phe Ala Tyr Val Thr Asp Gly Ala Cys Ser Gly Asp 
    210                 215                 220                 


Glu Ile Leu Thr Met Glu Leu Met Ile Met Lys Ala Leu Lys Trp Arg 
225                 230                 235                 240 


Leu Ser Pro Leu Thr Ile Val Ser Trp Leu Asn Val Tyr Met Gln Val 
                245                 250                 255     


Ala Tyr Leu Asn Asp Leu His Glu Val Leu Leu Pro Gln Tyr Pro Gln 
            260                 265                 270         


Gln Ile Phe Ile Gln Ile Ala Glu Leu Leu Asp Leu Cys Val Leu Asp 
        275                 280                 285             


Val Asp Cys Leu Glu Phe Pro Tyr Gly Ile Leu Ala Ala Ser Ala Leu 
    290                 295                 300                 


Tyr His Phe Ser Ser Ser Glu Leu Met Gln Lys Val Ser Gly Tyr Gln 
305                 310                 315                 320 


Trp Cys Asp Ile Glu Asn Cys Val Lys Trp Met Val Pro Phe Ala Met 
                325                 330                 335     


Val Ile Arg Glu Thr Gly Ser Ser Lys Leu Lys His Phe Arg Gly Val 
            340                 345                 350         


Ala Asp Glu Asp Ala His Asn Ile Gln Thr His Arg Asp Ser Leu Asp 
        355                 360                 365             


Leu Leu Asp Lys Ala Arg Ala Lys Lys Ala Met Leu Ser Glu Gln Asn 
    370                 375                 380                 


Arg Ala Ser Pro Leu Pro Ser Gly Leu Leu Thr Pro Pro Gln Ser Gly 
385                 390                 395                 400 


Lys Lys Gln Ser Ser Gly Pro Glu Met Ala 
                405                 410 


<210>  2
<211>  28
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  2
ttcttgagca acaccctctt ctgcagcc                                          28


<210>  3
<211>  32
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  3
tcgccatata ccggtcaaag aaatcttgtg cc                                     32


<210>  4
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  4
tcacccacac tgtgcccatc tacga                                             25


<210>  5
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  5
tgaggtagtc agtcaggtcc cg                                                22


<210>  6
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  6

Arg Ser Arg Lys Arg Lys 
1               5       


